These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 15516024
1. Serum albumin-adjusted phenytoin levels: an approach for predicting drug efficacy in patients with epilepsy, suitable for developing countries. Tandon M, Pandhi P, Garg SK, Prabhakar SK. Int J Clin Pharmacol Ther; 2004 Oct; 42(10):550-5. PubMed ID: 15516024 [Abstract] [Full Text] [Related]
2. Plasma total phenytoin: a possibly misleading test in developing countries. Fedler C, Stewart MJ. Ther Drug Monit; 1999 Apr; 21(2):155-60. PubMed ID: 10217333 [Abstract] [Full Text] [Related]
3. Free phenytoin assessment in patients: measured versus calculated blood serum levels. Tobler A, Hösli R, Mühlebach S, Huber A. Int J Clin Pharm; 2016 Apr; 38(2):303-9. PubMed ID: 26746902 [Abstract] [Full Text] [Related]
4. Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations. Krasowski MD, Penrod LE. BMC Med Inform Decis Mak; 2012 Feb 14; 12():7. PubMed ID: 22333264 [Abstract] [Full Text] [Related]
5. Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients. Hong JM, Choi YC, Kim WJ. Yonsei Med J; 2009 Aug 31; 50(4):517-20. PubMed ID: 19718399 [Abstract] [Full Text] [Related]
6. Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient. Mlynarek ME, Peterson EL, Zarowitz BJ. Ann Pharmacother; 1996 Mar 31; 30(3):219-23. PubMed ID: 8833553 [Abstract] [Full Text] [Related]
7. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children. Wolf GK, McClain CD, Zurakowski D, Dodson B, McManus ML. Pediatr Crit Care Med; 2006 Sep 31; 7(5):434-9; quiz 440. PubMed ID: 16885794 [Abstract] [Full Text] [Related]
8. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy. Kodama H, Kodama Y, Shinozawa S, Kanemaru R, Itokazu N, Sugimoto T. Int J Clin Pharmacol Ther; 2000 Jan 31; 38(1):25-9. PubMed ID: 10667833 [Abstract] [Full Text] [Related]
9. [Clinical significance of correcting the serum level of phenytoin according to the albuminaemia in hospitalized patients and outpatients]. Hermida-Ameijeiras J, Montero-Furelos C, Tutor-Valcarce JC. Rev Neurol; 2000 Jan 31; 37(10):909-12. PubMed ID: 14634917 [Abstract] [Full Text] [Related]
10. Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill Patients. Buckley MS, Reeves BA, Barletta JF, Bikin DS. Ann Pharmacother; 2016 Apr 31; 50(4):276-81. PubMed ID: 26783351 [Abstract] [Full Text] [Related]
12. Optimization of phenytoin therapy in adults with epilepsy in the Western Cape, South Africa. Valodia PN, Seymour MA, Kies BM, Folb PI. J Clin Pharm Ther; 1999 Oct 31; 24(5):381-5. PubMed ID: 10583702 [Abstract] [Full Text] [Related]
13. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications. Shaikh AS, Guo R. Curr Pharm Biotechnol; 2017 Oct 31; 18(13):1098-1105. PubMed ID: 29437004 [Abstract] [Full Text] [Related]
14. Estimation of Free Phenytoin Concentration in Critically Ill Patients with Hypoalbuminemia: Direct-measurement vs Traditional Equations. Wilfred PM, Mathew S, Chacko B, Prabha R, Mathew BS. Indian J Crit Care Med; 2022 Jun 31; 26(6):682-687. PubMed ID: 35836626 [Abstract] [Full Text] [Related]
15. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction. Montgomery MC, Chou JW, McPharlin TO, Baird GS, Anderson GD. Pharmacotherapy; 2019 Jul 31; 39(7):756-766. PubMed ID: 31067355 [Abstract] [Full Text] [Related]
16. No gender effect on binding characteristics of phenytoin to serum proteins in monotherapy for adult patients with epilepsy. Kodama H, Kodama Y, Shinozawa S, Kanemaru R, Todaka K, Mitsuyama Y. Am J Ther; 2000 Sep 31; 7(5):285-9. PubMed ID: 11317172 [Abstract] [Full Text] [Related]
17. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding. Iwamoto T, Kagawa Y, Naito Y, Kuzuhara S, Okuda M. Biopharm Drug Dispos; 2006 Mar 31; 27(2):77-84. PubMed ID: 16308884 [Abstract] [Full Text] [Related]
18. Accuracy of three methods for predicting concentrations of free phenytoin. Beck DE, Farringer JA, Ravis WR, Robinson CA. Clin Pharm; 1987 Nov 31; 6(11):888-94. PubMed ID: 3677566 [Abstract] [Full Text] [Related]
19. Antiepileptic TDM pattern at a tertiary care hospital in India. Jose VM, Medhi B, Pandhi P. Nepal Med Coll J; 2006 Jun 31; 8(2):107-10. PubMed ID: 17017400 [Abstract] [Full Text] [Related]